Introducing Stem Cell Innovations!
Stem Cell Innovations (SCI) is a network of highly motivated researchers, expert medical professionals, dedicated investors, and innovative engineers working together to create a unique platform that brings together two of the most life-changing innovations of the 21st century: stem cell technology and blockchain technology.
Since its initial founding in early 2013 under the name Camden RAD, LLC, SCI has played a crucial role in stem cell research and development around the world, and we have conducted our own domestic and international case studies to further the research in this exciting field. SCI’s activities in the field of stem cell science have directly contributed to advancements in the field, as well as to new stem cell discoveries around the world.
Introduction
Stem cells are a unique type of multicell found in the body of human beings. It is an undifferentiated collection of cells that are capable of providing countless applications in the development of new cells for use in the treatment of diseases and conditions, recovery and restoration of body parts.
Meanwhile, To date, Stem Cell Innovations (SCI) areas of study have included orthopedic, neurological, and pulmonary conditions, as well as oncological stem cell applications. Based on their Whitepaper, SCI have been able to identify countless applications for stem cell therapies including treatments for conditions such as bone marrow transplants, strokes, traumatic brain injuries, learning disorders, Alzheimer’s disease, missing teeth, wound healing, spinal cord injury, baldness, blindness, deafness, diabetes, Crohn’s disease, and multiple forms of cancer, as well as numerous other conditions.
SCI, along with its affiliates, continues to closely monitors the evolution of stem cell therapy in different medical subspecialties around the world. SCI has created an online community that shares important information from stem cell professionals’ research and contributions across multiple social platforms so there is congruity amongst key players and those that are most interested in stem cell research and the impact it can make on people’s lives. Also, SCI’s network fosters a community where sharing and teaching are encouraged to grow the stem cell industry. SCI’s online community offers access to videos, blogs, and articles about stem cell research that educate, inform, engage, and aim to increase awareness amongst professionals, patients and investors in the proliferation of the stem cell field.
The vision
Stem Cell Innovations ultimate goal is to connect people who need treatment with a dedicated team of professionals who can provide personalized solutions based on patient factors and demographics in dual blockchain-supported SCI platforms.
SCI is building a Stem Cell Innovation Application (SCIApplication) where communication, access and connection transactions can be done comfortably and available when needed. With so much information at our fingertips, it's only a matter of time before research and treatment of stem cells become mainstream and SCI is ready to conduct research and treatment to the next level. What's more, the same connection will facilitate determining how much information is shared, who to share, and when based on patient preferences.
SCI's vision is to provide a secure storage solution for users' medical data and give users control over their respective stem cell records. Data related to the user's stem cell needs will be stored on the SCI blockchain. The data will be accessible through a secure SCI application. With access to the SCI application, users will have the ability to not only share but also limit the information that can be seen by doctors and medical organizations in individual medical profiles. Users will also have the ability to provide access to network providers to view stem cell records that are owned separately for a limited time to facilitate care or consultation.
In addition to providing safe access to users' medical information, the application of SCIA will allow users to register seamlessly for life insurance policies, spinal cord registrars, and organ donor registrants. In addition, the SCI Application will also allow users to access their individual stem cell profiles, which will facilitate access to stem cell therapy and services in an easy and straightforward manner.Meanwhile, To date, Stem Cell Innovations (SCI) areas of study have included orthopedic, neurological, and pulmonary conditions, as well as oncological stem cell applications. Based on their Whitepaper, SCI have been able to identify countless applications for stem cell therapies including treatments for conditions such as bone marrow transplants, strokes, traumatic brain injuries, learning disorders, Alzheimer’s disease, missing teeth, wound healing, spinal cord injury, baldness, blindness, deafness, diabetes, Crohn’s disease, and multiple forms of cancer, as well as numerous other conditions.
SCI, along with its affiliates, continues to closely monitors the evolution of stem cell therapy in different medical subspecialties around the world. SCI has created an online community that shares important information from stem cell professionals’ research and contributions across multiple social platforms so there is congruity amongst key players and those that are most interested in stem cell research and the impact it can make on people’s lives. Also, SCI’s network fosters a community where sharing and teaching are encouraged to grow the stem cell industry. SCI’s online community offers access to videos, blogs, and articles about stem cell research that educate, inform, engage, and aim to increase awareness amongst professionals, patients and investors in the proliferation of the stem cell field.
The vision
Stem Cell Innovations ultimate goal is to connect people who need treatment with a dedicated team of professionals who can provide personalized solutions based on patient factors and demographics in dual blockchain-supported SCI platforms.
SCI is building a Stem Cell Innovation Application (SCIApplication) where communication, access and connection transactions can be done comfortably and available when needed. With so much information at our fingertips, it's only a matter of time before research and treatment of stem cells become mainstream and SCI is ready to conduct research and treatment to the next level. What's more, the same connection will facilitate determining how much information is shared, who to share, and when based on patient preferences.
SCI's vision is to provide a secure storage solution for users' medical data and give users control over their respective stem cell records. Data related to the user's stem cell needs will be stored on the SCI blockchain. The data will be accessible through a secure SCI application. With access to the SCI application, users will have the ability to not only share but also limit the information that can be seen by doctors and medical organizations in individual medical profiles. Users will also have the ability to provide access to network providers to view stem cell records that are owned separately for a limited time to facilitate care or consultation.
The SCIA application and website will fully comply with the 1996 privacy regulation Health Insurance Portability and Accountability Act (HIPAA) and will keep user information safe and secure. In an emergency, users will be able to provide medical history to emergency responders in seconds via the SCIApplication on the user's phone.
Information, such as the name and dosage of the drug, as well as previous operations and other medical information, can be very important in emergency situations. This information will be stored in the SCIA application so that emergency service providers can quickly access, understand, and provide necessary medical attention based on user profiles and information that can be accessed.
The aim of SCI is to bring stem cell therapy into the main medical community while providing harmonious access to medical records for patients and their doctors. This is the vision of SCI to empower patients and reduce inefficiencies in their access to medical care worldwide.
Stem Cell Innovations - Roadmap
The Innovations
The functionalities of blockchain technology and smart contracts provide an opportunity in the healthcare system to reinvent decades-old systems of data sharing, storing, and management supporting stem cell data integrity and security while giving patients control over their own data.Stem Cell Innovations - Unique Identifier
To ensure security and privacy, Key Cell Innovation will require users to enter the SCIA application to provide information and produce unique identifiers in the SCI ecosystem. A unique identifier is an alphanumeric string of information that is specified for a particular piece of data in an electronic database; in this case, the SCI platform and application. Users will be given a unique identifier that will be generated using proprietary algorithms, which will be used and stored using blockchain technology.
The unique SCI identifier will act as a user key in the SCI network. Through the cryptographic method, the data used to generate the key will be kept confidential and secure, can only be decomposed by the SCI decoder. And as SCI networks and service packages develop, users who choose this service will know the progress and new treatment options when they are available.
Stem Cell Innovations - Dual Blockchain
SCI plans to run on the dual blockchain platform. The first platform will be built on the basis of Ethereum only for the use of tokens and will be supported by the ERC20 platform. The second blockchain will be a special application designed and built by SCI engineers that are tailored to suit the healthcare environment.
SCI builds its own Blockchain to store and process patient stem cell recordings, this special Blockchain is known as SCIChain. SCIChain will use the Hyperledger Fabric network, which will be designed to use smart contracts to protect data and ensure that only authorized individuals have access to user data. The Hyperledger Fabric blockchain has a unique function that is different from other blockchain types to suit SCI's vision and product needs.
The SCIChain and SCIA applications operate vertically while ensuring transaction integrity and security. SCI believes that it can achieve data integrity and security using unique language and controls. Credentials will also run vertically between SCIChain and SCIApplication, ensuring high-level authentication for professionals, providers, users, and all members of the SCI network. Furthermore, SCI is working on a wider project to create separate blockchain for different stem cell specializations, ensuring further data security in various fields of study.
Stem Cell Innovations - Hyperledger Fabric
Hyperledger Fabric enables SCIApplication to be portable, private, and scalable. Hyperledger Fabric’s unique topology allows SCIChain to interact securely with our network providers’ systems. SCIChain will carry the SCI unique identifier within the blockchain to privatize and authenticate - ensuring the highest level of security within SCIApplication.
Hyperledger Fabric data remains isolated inside the blockchain, The use of a privatized network provides robust security as well as the ability to scale the use case on blockchain technology. Furthermore, SCI will be able to ensure HIPAA compliance by allowing portability on SCIChain.
Hyperledger Fabric utilizes many key factors that will allow SCI to carry out its plan to collect, store, and share information among certified networks in the stem cell community.
Hyperledger Fabric models provide the ability to:
- use key-based lookups, or unique identifiers, SCI can query and update data
- perform rich or read-only queries for a deeper understanding of data
- perform transactions using a unique identifier in chain code
- collect and verify unique signatures of data
- perform transactions and deliver a service to peers in the SCI network
- validate transactions and endorse the consensus
- verify consistency in data and reduce the compromise of data once verified
- collect and store various data from membership or network certificate authorities in the SCI network.
The SCIA application will use smart contracts to provide business logic that is safe for users and allows dynamic settings at the user's request. All users can set their unique preferences in the SCIA application. Smart contracts will allow users to determine which stem cell providers they like in the SCIA application, assign stem cell records to the list of doctors, labs, or entities of their choice. Smart contracts will be saved on SCIChain (SCI's secondary special blockchain). Every block at SCIC will bring all smart contracts to ensure security, allow speed, and provide guarantees.
Smart contracts are gatekeepers of the SCIA application, Users will be free to change their settings at will if their care changes or preferences change. Using the same mathematical equation as the ERC20 platform, SCI ensures user privacy. Direct validation related to the blockchain environment is a secure process that ensures data integrity. Furthermore, cryptographic public keys will be added to SCIChain and applications to promote higher security standards. The encrypted symmetric key used by SCIChain is 2048 bits, which is a method highly secure data transformation in the world based on current technology.
Stem Cell Innovations - Data Structure
Hyperledger Fabric allows SCI to use multiple languages to communicate with current Electronic Medical Records and Health Electronic Records (EMR/HER) systems. HIPAA regulations need to be considered at all access points where medical data is concerned.
The SCI system uses double-encryption methodology on a private blockchain designed by SCI. The data are private and not accessible to anyone outside the blockchain or the network curated by SCI.
In addition, there will be an auditing trail that will monitor changes on the blockchain and will enable the viewing of the history of stem cell records from creation to a set point in time. Record trails allow SCI to find errors, debug issues, improve the customized blockchain, and report on network functional views to upgrade SCI’s blockchain as needed.
SCI will implement the smart contract on the ERC20 platform, which enables secure distribution of currency via public key cryptography. These transactions carry unique, cryptographically-signed agreements to complete the values of the transactions. The smart contract attribute will follow particular instructions and update the entire blockchain to ensure a high level of security and data integrity.
The ultimate goal of the SCIApplication is to give users control over their own stem cell data while storing and processing that data in a decentralized way to ensure data integrity and security. Decentralization enables an SCI user to access our network of stem cell services and therapies without having to wait for time-consuming referrals, wait-lists for treatments, and access to their own information.
The private nature of the data SCI will handle through its application requires maximum security and care; therefore, SCI has developed a process of approving new nodes on the blockchain network that will ensure the security and integrity of user data remain safe.
At a minimum, creating new nodes on the SCI blockchain will need to meet the following requirements:
- Applying transparent encryption to protect sensitive data at the string or bit level in NoSQL databases (Cassandra, MongoDB, and HBase, etc.) and SQL databases (Microsoft SQL Server, Oracle, IBM DB2, MySQL, PostgreSQL, etc.);
- Defining smart contracts using SCIChain to control who and what can access the data, including database administrators and other privileged users;
- Using SCI unique identification as a key and policy for management and operations, auditing capability on database transactions.
Stem Cell Innovations Token Overview
The Stem Cell Innovations token will be implemented as an ERC-20 token over the Ethereum public blockchain. The token will primarily be used within the SCI ecosystem as a method for users to access the full range of SCI products and services. Given the self-contained nature of the ecosystem, a token-based model for product usage will support security and exclusivity of access for SCIApplication token holders, which will, in turn, drive the fundamental value of the token.
The primary use case for the token will be the purchase of products and services through the SCI ecosystem. The token will be the exclusive means of purchasing within the ecosystem. As additional applications and services are added to the ecosystem, the token will gain utility as a means to access these new products.
Token Sale
SCI’s goal is to raise a maximum of $36,000,000 and a minimum of $3,000,000. Some of these numbers may change with ETH/USD exchange rates and volatility throughout the ICO and launch phase of the company’s growth. This document is based on exchange rate estimates at the time of writing. SCI will mint a total of 800 million tokens. Of these, 240 million tokens will be available during the token sale to start on September 17, 2018.
Each token will be sold at $0.15. Should all 240 million tokens be sold, the raised funds will be $36,000,000. Tokens unsold from the 240 million will be burned. The funds raised during the token sale are to be used per the project roadmap above.
Token sale information;
- Start date: 00:00 a.m. (GMT) on September 17, 2018
- End Date: 00:00 a.m. (GMT) on January 17, 2019
- Payment methods accepted: BTC, ETH, LTC, FIAT
- Soft cap: $3,000,000
- Hard cap: $36,000,000
- Token Sale price: $0.15
- Total token supply (max): 800,000,000
- Min purchase Pre-Sale: $500 USD
- Min purchase Main-Sale: 0.4 ETH
- Max purchase: 4000 ETH
TOKEN SALE NOW LIVE!
The total number of tokens sold during the pre-sale period cannot exceed 60% of the total number of tokens initially put up for sale by the Main-Sale. If the number of requests received during the pre-sale period exceeds, a request will be honored in the chronological order in line with the set limit, and excess orders will be returned to clients.
SCI roadmap assumes development of essential features for the SCI platform and includes strong sales and marketing support to accelerate adoption.
Also, SCI will consider the usage of reserve tokens over a period of time both pre- and post-launch. The number of reserve tokens cannot be fixed due to the nature of the sales and bonus offers. SCI may choose to burn tokens or consider distributions at SCI’s discretion under the following headings (non-exhaustive) and initially suggested allocations:
The SCI team and advisory committee are represented by world-class professionals in their fields and together, they bring about the successes of the company and its life-changing work.
The Team
The Team
Moe Galal (Chief Executive Officer / Founder), Moe is a founder of SCI and hopes to usher in the next generation of medicine using stem cells and other technological advancements relying on his 20+ years of experience in the business.
Ben Barel (Chief Operations Officer / Co-Founder), With more than twenty years of progressive corporate healthcare managing operations experience. Carrying demonstrated track record of driving margin improvement and operational efficiency.
Ali Alrashidi (Chief Technology Officer / Co-Founder), A background rich in programming and development, Ali manages SCI’s blockchain platform. Ali’s support in furthering academic research in the field of blockchain will allow SCI to grow.
In addition to the 3 names above, the SCI Team consists of the people of experts in their fields, including; Matt Galal (Chief of Staff / Co-Founder), Kobi Barel (Operations Engineer / Co-Founder), John Glavinovich, M.D. (Medical Director), Philip Glukhovsky, D.C. (Health Informatics Manager), Roger Williams (VP of Marketing), Liz Curlett (VP, PR & Corporate Communications), Candice Kouchache (Business Development), Ahmed Elsantawi (VP of International Human Resources), David Marmon (Web Designer), Heather Deveaux (Copywriter), Everlecia Taylor (Creative Writer), Marina Evglevskaya (Administrative Manager), Rakel Apodaca (Product Manager), Michelle Chavon (Marketing).
Ben Barel (Chief Operations Officer / Co-Founder), With more than twenty years of progressive corporate healthcare managing operations experience. Carrying demonstrated track record of driving margin improvement and operational efficiency.
Ali Alrashidi (Chief Technology Officer / Co-Founder), A background rich in programming and development, Ali manages SCI’s blockchain platform. Ali’s support in furthering academic research in the field of blockchain will allow SCI to grow.
In addition to the 3 names above, the SCI Team consists of the people of experts in their fields, including; Matt Galal (Chief of Staff / Co-Founder), Kobi Barel (Operations Engineer / Co-Founder), John Glavinovich, M.D. (Medical Director), Philip Glukhovsky, D.C. (Health Informatics Manager), Roger Williams (VP of Marketing), Liz Curlett (VP, PR & Corporate Communications), Candice Kouchache (Business Development), Ahmed Elsantawi (VP of International Human Resources), David Marmon (Web Designer), Heather Deveaux (Copywriter), Everlecia Taylor (Creative Writer), Marina Evglevskaya (Administrative Manager), Rakel Apodaca (Product Manager), Michelle Chavon (Marketing).
Conclusion
The Stem Cell Innovation Project is trying to change the face of healthcare by expanding access to research, development, and treatment of stem cells worldwide using blockchain technology.
And as a leader in stem cell research, SCI plans to continue to organize and participate in many more case studies to aggregate data that can be used to advance this innovative field. While advancements have been made in stem cell research previously, the introduction of blockchain technology means that more people can gain access to these potentially life-changing treatments - effectively changing the face of the medical community forever.
The SCI moves to bridge the gap between accessing and understanding of stem cell research and development around the world while creating a collaborative and effective network of key players in the industry.
Overall, the SCI project can you consider as your next investment. However, readers are encouraged to do own research before finally deciding to do the investment.
For your more research, please visit the link below:
- Website: www.scia.io
- Email: info@scia.io
- Twitter: www.twitter.com/stemcellapp
- Facebook: www.facebook.com/stemcellapp
- Telegram: t.me/stemcellinnovations
- Medium: medium.com/@scia
- Reddit: www.reddit.com/r/SCIA
- LinkedIn: www.linkedin.com/company/stemcell-innovations
Author: Yusuf jay
Bountyhive Referral Link: bountyhive.io/r/Yusufjay
No comments:
Post a Comment